# About Online Wolverine — An independent reading room for the BPC-157 + TB-500 literature

> Online Wolverine is an independent editorial publication that summarizes the peer-reviewed research literature on the BPC-157 + TB-500 peptide blend. Not a clinic, not a pharmacy, not affiliated with any vendor.

Online Wolverine is an independent editorial project that reads and indexes the peer-reviewed research on the BPC-157 + TB-500 blend.

## What we are

Online Wolverine is an independent editorial project that publishes summaries of the peer-reviewed research literature on the BPC-157 + TB-500 peptide blend. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The "online" in our name refers to the medium — open the browser, read the page, follow the citation to the open-access paper if it lives in PMC. We are not an online clinic, an online pharmacy, an online dispensary, or a telehealth service. The "Wolverine" in our name is internet folklore — the community nickname for the BPC-157 + TB-500 blend — borrowed from a pop-culture character in a separate intellectual-property universe and used as the domain modifier only because that is the name a reader is likely to type into a search bar. The publication takes no position on the character or the IP.

## What we publish

Six pages of editorial work, indexed and cross-linked. The /research page reads the preclinical and clinical literature on each component peptide and on the absent combination evidence. The /dosage page reports the dose values that appear in the published rodent and human ophthalmic protocols. The /faq page answers the twelve questions that turned up most often in the search-intent corpus. The /references page indexes the full citation list with DOIs, PubMed IDs, and PMC links. The /contact page is a single contact form.

The site does not interlink with any other domain in the publisher's catalogue. The only outbound links on the site are to legitimate primary sources — PubMed, PubMed Central, journal publisher landing pages, and the FDA, WADA, and ClinicalTrials.gov where regulatory context warrants. We do not promote, endorse, or refer to any vendor of any peptide.

## Editorial standards

Every quantitative claim on the site is sourced to a paper indexed on PubMed or hosted by its journal publisher. Dose values, half-life numbers, study counts, and percentages cite the underlying study by number. The page-level word counts and the cross-page consistency of dose values (the 10 μg/kg IP figure for BPC-157 in rodent tendon, ligament, muscle, and colitis work; the 6 mg/kg figure for Tβ4 in the rat embolic-stroke model; the 0.1% topical figure for Tβ4 in the human ophthalmic trials) are checked against the source citations during each edit pass.

We do not write prescriptive language. We do not recommend doses for human use of either compound. We describe what was studied and what the published trial protocols administered, in the third person, with study attribution. We avoid hyperbolic anti-use framing for the same reason we avoid promotional framing — both distort the literature.

## Disclaimer

Online Wolverine is an independent editorial project that reads, indexes, and summarizes the peer-reviewed research literature on the BPC-157 + TB-500 peptide blend. Nothing on this site is medical advice. Neither BPC-157 nor TB-500 is approved by the U.S. Food and Drug Administration for any human indication; both were placed on the FDA's Category 2 list of bulk drug substances of safety concern in September 2023. TB-500 is prohibited at all times by the World Anti-Doping Agency under category S2; BPC-157 is listed under WADA category S0. The publisher does not manufacture, sell, or distribute any product and is not affiliated with any vendor or manufacturer. This is an editorial reading of the published record — not a clinic, not a pharmacy, not a recommendation.

---

An editorial reading of the published research — not a clinic, not a vendor, not medical guidance.
